STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Monte Rosa Therapeutics, Inc
Adela, Inc
OncoNano Medicine, Inc.
Incyte Corporation
AVM Biotechnology Inc
Tempus AI
Intensity Therapeutics, Inc.
RAPT Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Actuate Therapeutics Inc.
VitaMed Research LLC
Celldex Therapeutics
Eisai Inc.
Cellestia Biotech AG
Corvus Pharmaceuticals, Inc.
Fate Therapeutics
Pfizer
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
Eli Lilly and Company
GlaxoSmithKline
AstraZeneca
Celgene
LEO Pharma
AbbVie
Novartis
Incyte Corporation
Amgen
Lytix Biopharma AS
sigma-tau i.f.r. S.p.A.
Incyte Corporation
GlaxoSmithKline
Sandoz
Valerio Therapeutics
INSYS Therapeutics Inc
Altor BioScience
Novartis
Mast Therapeutics, Inc.
Cylene Pharmaceuticals
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Amgen
Amgen
Pfizer